We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+9.67%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$98.6B
AUM Growth
+$9.82B
Cap. Flow
+$3.18B
Cap. Flow %
3.23%
Top 10 Hldgs %
34.51%
Holding
3,532
New
899
Increased
935
Reduced
953
Closed
698

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$3.93B
2
MSFT icon
Microsoft
MSFT
+$556M
3
COR icon
Cencora
COR
+$492M
4
NFLX icon
Netflix
NFLX
+$452M
5
BAC icon
Bank of America
BAC
+$411M

Sector Composition

Rank Sector Weight
1 Technology 20.19%
2 Consumer Discretionary 12.64%
3 Healthcare 9.35%
4 Financials 8.34%
5 Communication Services 6.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AIP icon
1676
Arteris
AIP
$1.34B
$1.69M ﹤0.01%
167,290
+30,062
+22% +$286K
C icon
1677
PUT
Citigroup
C
$222B
$1.68M ﹤0.01%
16,600
-500
-3% -$47.4K
NTSK
1678
Netskope Inc
NTSK
$4.84B
$1.68M ﹤0.01%
+74,072
New +$1.76M
AVAV icon
1679
AeroVironment
AVAV
$7.91B
$1.68M ﹤0.01%
5,343
-18,845
-78% -$4.88M
GOGO icon
1680
Gogo Inc
GOGO
$550M
$1.68M ﹤0.01%
195,015
-124,200
-39% -$1.57M
MRBK icon
1681
Meridian
MRBK
$241M
$1.67M ﹤0.01%
105,998
+5,199
+5% +$78K
APAM icon
1682
Artisan Partners
APAM
$2.9B
$1.67M ﹤0.01%
+38,563
New +$1.78M
OPBK icon
1683
OP Bancorp
OPBK
$241M
$1.67M ﹤0.01%
120,065
-20,526
-15% -$284K
SI
1684
Shoulder Innovations Inc
SI
$503M
$1.67M ﹤0.01%
+132,888
New +$1.86M
ANAB icon
1685
AnaptysBio
ANAB
$1.54B
$1.67M ﹤0.01%
+54,416
New +$1.25M
ATRA icon
1686
Atara Biotherapeutics
ATRA
$70.4M
$1.66M ﹤0.01%
115,796
+73,441
+173% +$845K
RNR icon
1687
RenaissanceRe
RNR
$13.9B
$1.66M ﹤0.01%
+6,524
New +$1.58M
DHIL
1688
DELISTED
Diamond Hill
DHIL
$1.66M ﹤0.01%
11,826
+4,412
+60% +$644K
HRTX icon
1689
Heron Therapeutics
HRTX
$92M
$1.65M ﹤0.01%
1,308,861
-1,585,211
-55% -$2.51M
BWFG icon
1690
Bankwell Financial Group
BWFG
$533M
$1.64M ﹤0.01%
+37,165
New +$1.53M
RC
1691
Ready Capital
RC
$261M
$1.64M ﹤0.01%
424,288
-1,072,841
-72% -$4.53M
EVEX icon
1692
Eve Holding
EVEX
$853M
$1.64M ﹤0.01%
430,578
+383,070
+806% +$2.04M
AVXL icon
1693
Anavex Life Sciences
AVXL
$238M
$1.62M ﹤0.01%
182,190
JBTM
1694
JBT Marel
JBTM
$7.59B
$1.62M ﹤0.01%
+11,524
New +$1.57M
XLE icon
1695
PUT
State Street Energy Select Sector SPDR ETF
XLE
$38.3B
$1.62M ﹤0.01%
36,200
-726,200
-95% -$31.8M
NYAX
1696
Nayax
NYAX
$2.57B
$1.62M ﹤0.01%
33,964
-18,737
-36% -$871K
FNB icon
1697
FNB Corp
FNB
$6.81B
$1.61M ﹤0.01%
+99,910
New +$1.59M
CGXU icon
1698
Capital Group International Focus Equity ETF
CGXU
$6.15B
$1.6M ﹤0.01%
54,123
+45,600
+535% +$1.27M
SBS icon
1699
Sabesp
SBS
$19.4B
$1.59M ﹤0.01%
+330,317
New +$1.39M
CWBC
1700
Community West Bancshares
CWBC
$693M
$1.59M ﹤0.01%
76,153
+20,702
+37% +$426K

Similar funds

Marshall Wace's Q3 2025 Portfolio in Review

As of Q3 2025, Marshall Wace held 3,532 positions worth $98.6B, up 11% from $88.8B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Marshall Wace deployed $3.18B of net new capital in Q3 2025, opening 899 new positions and adding to 935 existing holdings. Its largest new stake was Texas Instruments: 1,537,539 shares worth $282M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $636M trimmed.

  • Marshall Wace's largest Q3 2025 buy was Texas Instruments: 1,537,539 shares worth $282M.
  • Marshall Wace added most to iShares Core S&P 500 ETF in Q3 2025, an estimated $3.93B increase.
  • Marshall Wace's biggest Q3 2025 reduction was Alphabet (Google) Class A, cutting an estimated $636M.
  • Marshall Wace fully exited AT&T in Q3 2025, selling an estimated $235M.
  • Marshall Wace's ten largest holdings make up 35% of its $98.6B portfolio in Q3 2025.
  • Marshall Wace opened 899 new positions and closed 698 in Q3 2025.
  • Marshall Wace's portfolio value rose 11% quarter-over-quarter to $98.6B.

Based on Marshall Wace's 13F filing for Q3 2025, filed 13 Nov 2025.